|
| Raptiva Description:
Raptiva,Efalizumab, is a medicine used to treat adult patients with moderate to severe plaque psoriasis whose psoriasis is appropriate for treatment with whole body (systemic therapy) or phototherapy. Raptiva has not been studied in children under 18 years of age.
Active Ingredient: efalizumab
Strength(s): 125 mg
Dosage Form(s): subcutaneous injection |
Product Notes:
Who should not use Raptiva?
Do not use Raptiva if you have ever had an allergic reaction to Raptiva.
Special Warnings with Raptiva:
Raptiva can decrease the activity of your immune system. Therefore, people using Raptiva may have an increased chance of getting:
serious infections
cancers
low platelet counts (thrombocytopenia)
worsening of psoriasis
You should not receive vaccines while using Raptiva. Raptiva may prevent a vaccine from working.
What should I tell my health care provider?
Tell your health care provider if you:
are pregnant or are planning to become pregnant
are breast feeding
have any infections
have immune system problems
have had cancer
Tell your health care provider about all the medicines you take including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially, tell your healthcare provider if you are using:
other medicines or treatments for your psoriasis
medicines called immunosuppressives or any medicine that affects your immune system Side Effects:
The most common side effects of Raptiva include:
headache
chills
fever
nausea
muscle aches Manufacturer link or canadian Pharmacy drug sources: na
|
